Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways. Issue 1 (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways. Issue 1 (1st January 2020)
- Main Title:
- Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways
- Authors:
- Xu, Wan-Ting
Li, Tian-Zhu
Li, Shu-Mei
Wang, Cheng
Wang, Hao
Luo, Ying-Hua
Piao, Xian-Ji
Wang, Jia-Ru
Zhang, Yu
Zhang, Tong
Xue, Hui
Cao, Long-Kui
Jin, Cheng-Hao - Abstract:
- Abstract: Cytisine is a natural product isolated from plants and is a member of the quinolizidine alkaloid family. This study aims to investigate the effect of cytisine in human lung cancer. Cell viability was determined using the CCK-8 assay, and the results showed that cytisine inhibited the growth of lung cancer cell lines. The apoptotic effects were evaluated using flow cytometry, and the results showed that cytisine induced mitochondrial-dependent apoptosis through loss of the mitochondrial membrane potential; increased expression of BAD, cleaved caspase-3, and cleaved-PARP; and decreased expression levels of Bcl-2, pro-caspase-3, and pro-PARP. In addition, cytisine caused G2/M phase cell cycle arrest that was associated with inhibiting the AKT signalling pathway. During apoptosis, cytisine increased the phosphorylation levels of JNK, p38, and I-κB, and decreased the phosphorylation levels of ERK, STAT3, and NF-κB. Furthermore, cytisine treatment led to the generation of ROS, and the NAC attenuated cytisine-induced apoptosis. In vivo, cytisine administration significantly inhibited the lung cancer cell xenograft tumorigenesis. In conclusion, cytisine plays a critical role in suppressing the carcinogenesis of lung cancer cells through cell cycle arrest and induction of mitochondria-mediated apoptosis, suggesting that it may be a promising candidate for the treatment of human lung cancer.
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 48:Issue 1(2020)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 48:Issue 1(2020)
- Issue Display:
- Volume 48, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 48
- Issue:
- 1
- Issue Sort Value:
- 2020-0048-0001-0000
- Page Start:
- 84
- Page End:
- 95
- Publication Date:
- 2020-01-01
- Subjects:
- Cytisine -- human lung cancer cell -- apoptosis -- cell cycle arrest -- reactive oxygen species
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2019.1699813 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25350.xml